Greenfire Resources: Initiating A Long Position — Positive

GFR   Seeking Alpha — November 05, 2025

Greenfire Resources (GFR:CA) trades at a discount due to limited investor relations initiatives but its assets are attractive. Q3 results were robust, with strong cash flow and production, though hedging and FX losses led to a small net loss for the quarter. GFR plans a C$300M rights offering to refinance expensive debt, but the expected 70-80% dilution raises concerns despite potential interest savings.

image for news Greenfire Resources: Initiating A Long Position

PHOENIX--(BUSINESS WIRE)-- #Colterpoint--Sponsor of Fundamental Income Net Lease Real Estate ETF (NYSE: NETL) Announces Rebranding to Colterpoint Net Lease Real Estate ETF (NYSE: NETL).

image for news Sponsor of The Fundamental Income Net Lease Real Estate ETF (NYSE: NETL) Announces Rebranding to The Colterpoint Net Lease Real Estate ETF (NYSE: NETL), and a 5.00% Increase to Monthly Dividend, Targeting 10.5 cents per Month, or ~$1.26 per Year

LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sonic Automotive, Inc. (“Sonic” or “the Company”) (NYSE: SAH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

image for news SAH Investors Have Opportunity to Join Sonic Automotive, Inc. Fraud Investigation with the Schall Law Firm

SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials in the U.S., alleging the company committed securities fraud by misleading investors about inventory levels and customer demand in its crucial North American segment. Hagens Berman is investigating the alleged claims and urges investors in James Hardie who suffered significant losses to contact the firm now.

image for news JHX INVESTOR ALERT: James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements -- Hagens Berman

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Every industrial revolution has a birthplace. The steam engine had Birmingham.

image for news Valladolid, Spain Takes the Lead as Europe's "Capital of Proof" for Circular Economies

American Financial Group: Q3 Results Send Mixed Signals — Neutral

AFG   Seeking Alpha — November 05, 2025

American Financial Group remains rated "Hold" due to mixed underwriting performance and limited premium growth despite a strong Q3 earnings beat. AFG benefited from a light catastrophe season, masking underlying weakness in core underwriting; combined ratios are expected to face persistent pressure. Investment income growth is capped by multifamily real estate exposure, with muted returns expected as rent growth slows in key markets.

image for news American Financial Group: Q3 Results Send Mixed Signals

KBRA Assigns Ratings to Bank of Marin Bancorp — Neutral

BMRC   Business Wire — November 05, 2025

NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a senior unsecured debt rating of BBB, a subordinated debt rating of BBB-, and a short-term debt rating of K3 to Novato, California-based Bank of Marin Bancorp (NASDAQ: BMRC) ("Marin" or "the company"). In addition, KBRA assigns deposit and senior unsecured debt ratings of BBB+, a subordinated debt rating of BBB, and short-term deposit and debt ratings of K2 to its main subsidiary, Bank of Marin. The Outlook for all long-term ratings is Stable. BMRC's rat.

image for news KBRA Assigns Ratings to Bank of Marin Bancorp

SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The firm urges investors in aTyr who suffered significant losses to submit your losses now.

image for news aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

AMD just passed one test — but an even bigger one sits on the horizon — Neutral

AMD   Market Watch — November 05, 2025

While Advanced Micro Devices' downward stock move on Wednesday may not suggest it, the chip maker passed Wall Street's test with its latest earnings report and commentary. Now investors are hungry for more substantial information, which could come next week at the company's analyst day.

image for news AMD just passed one test — but an even bigger one sits on the horizon

Can WDC's Revenue Momentum Continue on Rising Cloud and AI Demand? — Positive

WDC   Zacks Investment Research — November 05, 2025

Western Digital enters fiscal 2026 with surging cloud and AI demand, strong revenue growth and rising shipments of high-capacity drives.

image for news Can WDC's Revenue Momentum Continue on Rising Cloud and AI Demand?

CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls — Negative

CRL   Zacks Investment Research — November 05, 2025

Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.

image for news CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls

Southern Company Q3 Earnings Top on Usage, New Customers — Positive

SO   Zacks Investment Research — November 05, 2025

SO beats Q3 estimates as revenues and earnings climb on higher power usage and customer gains.

image for news Southern Company Q3 Earnings Top on Usage, New Customers

GCM Grosvenor Inc. (GCMG) Q3 Earnings and Revenues Surpass Estimates — Positive

GCMG   Zacks Investment Research — November 05, 2025

GCM Grosvenor Inc. (GCMG) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.16 per share a year ago.

image for news GCM Grosvenor Inc. (GCMG) Q3 Earnings and Revenues Surpass Estimates

Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates — Positive

ACB   Zacks Investment Research — November 05, 2025

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.

image for news Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates

Axon Dives On Q3 Miss, But Promises 'Really Big' Q4 — Neutral

AXON   Investors Business Daily — November 05, 2025

Axon signaled that federal contracting wins are coming, despite the shutdown.

image for news Axon Dives On Q3 Miss, But Promises 'Really Big' Q4

Icahn disclosed ownership of 4.4 million shares, or almost a 15% stake in Monro, according to a new regulatory filing.

image for news Auto repair chain Monro soars after Carl Icahn takes 15% stake to become largest shareholder

KBR Investors with Losses Encouraged to Contact the Firm Before Nov. 18th Deadline KBR Investors with Losses Encouraged to Contact the Firm Before Nov. 18th Deadline

image for news KBR 13-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms–Hagens Berman

Arista Q3 Earnings Beat Estimates on Solid Top-Line Improvement — Positive

ANET   Zacks Investment Research — November 05, 2025

ANET's Q3 earnings beat forecasts as robust demand, new product launches and margin gains power strong top-line growth.

image for news Arista Q3 Earnings Beat Estimates on Solid Top-Line Improvement

Grocery Outlet Beats on Q3 Earnings, Trims Comparable Sales Outlook — Neutral

GO   Zacks Investment Research — November 05, 2025

GO tops Q3 earnings expectations but lowers its 2025 comparable sales outlook amid softer late-quarter trends.

image for news Grocery Outlet Beats on Q3 Earnings, Trims Comparable Sales Outlook

Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead? — Positive

BSX   Zacks Investment Research — November 05, 2025

BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.

image for news Boston Scientific Sustains EP Momentum in Q3: Is More Upside Ahead?